The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Description of business:
Clinigen is a fast-growing global specialty pharmaceuticals and pharmaceutical services business dedicated to serving patients, the medical community and the healthcare industry. The Company currently employs 78 people across its operations and has a head office in Burton-on-Trent, UK, with further offices in Philadelphia, US and Tokyo, Japan. The Company’s primary country of operation is the UK. Clinigen was formed in 2010 and comprises two divisions - services and products. Within the services division, there are two businesses: ClinigenCTS, which offers clinical trial drug supply, and ClinigenGAP, which offers supply of medicines through global access programs. The products division owns and supplies Foscavir® (a hospital-only drug for the treatment of cytomegalovirus, which was acquired in 2010) and intends to acquire, and grow sales of, niche hospital-only drugs.

Back

Clinigen Group plc

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds